Latest Ethical Investing News

Australian Ethical Investment Ltd has released its 2026 reporting calendar, outlining important dates for financial disclosures, dividends, and corporate governance events.

Magellan Investment Partners has launched the Magellan Global Opportunities Fund, an actively managed ETF targeting long-term outperformance of the MSCI World Index with a strong ESG focus and reduced management fees.

Australian Ethical Investment Limited (AEF) has responded to ASX inquiries about additional licence conditions imposed on its subsidiary, Australian Ethical Superannuation Pty Ltd (AES), asserting these do not materially affect its securities value despite a notable share price drop.

InvestSMART Funds Management Limited has updated its Distribution Reinvestment Plan rules, making participation automatic for new investors in its Intelligent Investor Active ETFs from January 2026. Existing investors will see no change, but new entrants will need to opt out if they prefer cash distributions.

Shriro Holdings updates shareholders on proposed buy-backs that could reshape voting power, with major stakes changing hands and key players abstaining from votes.

Australian Ethical Investment Limited has delivered a standout FY25 with record funds under management and significant profit growth, setting the stage for its next growth phase.

Australian Ethical Investment Limited reported a robust 68% rise in net profit after tax and a 34% increase in funds under management for FY25, driven by strong organic growth and the Altius acquisition. The company declared a fully franked final dividend of 9 cents per share, underscoring confidence in its growth trajectory.

Morphic Ethical Equities Fund Limited reported a strong turnaround in FY2025 with a $5.44 million net profit and portfolio returns surpassing its benchmark, while continuing aggressive share buybacks despite withholding dividends.

Australian Ethical Investment Ltd has reported a record $13.94 billion in funds under management, driven by robust net inflows and disciplined ethical investing amid economic challenges.

Morphic Ethical Equities Fund Limited reported a robust turnaround with a $2.96 million profit after tax for the half-year ended December 2024, reversing last year’s losses despite no dividends declared.

Nova Eye Medical has completed a $6.6 million placement to fund growth initiatives, supported by strong global sales growth and a major shareholder commitment. The capital raise aims to bolster sales teams and product development as the company targets profitability in its glaucoma division.